Global Intravenous (IV) Iron Drugs Market Research Report Forecast 2017-2021

April 2017 | 116 pages | ID: GA8091C3616EN
S&P Consulting

Abstracts

The Global Intravenous (IV) Iron Drugs Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Intravenous (IV) Iron Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Intravenous (IV) Iron Drugs market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

Global Intravenous (IV) Iron Drugs Market: Regional Segment Analysis

North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:

AMAG Pharmaceuticals
Actavis
Galenica
Vifor Pharma
Luitpold Pharmaceuticals
Pharmacosmos A/S
American Regent
Fresenius Medical Care AG & Co. KGaA
Anofi US

Global Intravenous (IV) Iron Drugs Market: Product Segment Analysis

Type 1
Type 2
Type 3


Global Intravenous (IV) Iron Drugs Market: Application Segment Analysis

Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

Global Intravenous (IV) Iron Drugs Market Research Report Forecast 2017-2021

CHAPTER 1 INTRAVENOUS (IV) IRON DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Intravenous (IV) Iron Drugs
1.2 Intravenous (IV) Iron Drugs Market Segmentation by Type
  1.2.1 Global Production Market Share of Intravenous (IV) Iron Drugs by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Intravenous (IV) Iron Drugs Market Segmentation by Application
  1.3.1 Intravenous (IV) Iron Drugs Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Intravenous (IV) Iron Drugs Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Intravenous (IV) Iron Drugs (2012-2021)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON INTRAVENOUS (IV) IRON DRUGS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL INTRAVENOUS (IV) IRON DRUGS MARKET COMPETITION BY MANUFACTURERS

3.1 Global Intravenous (IV) Iron Drugs Production and Share by Manufacturers (2015 and 2016)
3.2 Global Intravenous (IV) Iron Drugs Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Intravenous (IV) Iron Drugs Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Intravenous (IV) Iron Drugs Manufacturing Base Distribution, Production Area and Product Type
3.5 Intravenous (IV) Iron Drugs Market Competitive Situation and Trends
  3.5.1 Intravenous (IV) Iron Drugs Market Concentration Rate
  3.5.2 Intravenous (IV) Iron Drugs Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL INTRAVENOUS (IV) IRON DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Intravenous (IV) Iron Drugs Production by Region (2012-2017)
4.2 Global Intravenous (IV) Iron Drugs Production Market Share by Region (2012-2017)
4.3 Global Intravenous (IV) Iron Drugs Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL INTRAVENOUS (IV) IRON DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Intravenous (IV) Iron Drugs Consumption by Regions (2012-2017)
5.2 North America Intravenous (IV) Iron Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Intravenous (IV) Iron Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Intravenous (IV) Iron Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Intravenous (IV) Iron Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Intravenous (IV) Iron Drugs Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Intravenous (IV) Iron Drugs Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL INTRAVENOUS (IV) IRON DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Intravenous (IV) Iron Drugs Production and Market Share by Type (2012-2017)
6.2 Global Intravenous (IV) Iron Drugs Revenue and Market Share by Type (2012-2017)
6.3 Global Intravenous (IV) Iron Drugs Price by Type (2012-2017)
6.4 Global Intravenous (IV) Iron Drugs Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL INTRAVENOUS (IV) IRON DRUGS MARKET ANALYSIS BY APPLICATION

7.1 Global Intravenous (IV) Iron Drugs Consumption and Market Share by Application (2012-2017)
7.2 Global Intravenous (IV) Iron Drugs Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL INTRAVENOUS (IV) IRON DRUGS MANUFACTURERS ANALYSIS

8.1 AMAG Pharmaceuticals
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Actavis
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Galenica
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 Vifor Pharma
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Luitpold Pharmaceuticals
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Pharmacosmos A/S
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 American Regent
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Fresenius Medical Care AG & Co. KGaA
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Anofi US
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 INTRAVENOUS (IV) IRON DRUGS MANUFACTURING COST ANALYSIS

9.1 Intravenous (IV) Iron Drugs Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Intravenous (IV) Iron Drugs

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Intravenous (IV) Iron Drugs Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Intravenous (IV) Iron Drugs Major Manufacturers in 2015
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL INTRAVENOUS (IV) IRON DRUGS MARKET FORECAST (2017-2021)

13.1 Global Intravenous (IV) Iron Drugs Production, Revenue Forecast (2017-2021)
13.2 Global Intravenous (IV) Iron Drugs Production, Consumption Forecast by Regions (2017-2021)
13.3 Global Intravenous (IV) Iron Drugs Production Forecast by Type (2017-2021)
13.4 Global Intravenous (IV) Iron Drugs Consumption Forecast by Application (2017-2021)
13.5 Intravenous (IV) Iron Drugs Price Forecast (2017-2021)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Intravenous (IV) Iron Drugs
Figure Global Production Market Share of Intravenous (IV) Iron Drugs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Intravenous (IV) Iron Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure Europe Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure China Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure Japan Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure Southeast Asia Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure India Intravenous (IV) Iron Drugs Revenue (Million USD) and Growth Rate (2012-2021)
Figure Global Intravenous (IV) Iron Drugs Revenue (Million UDS) and Growth Rate (2012-2021)
Table Global Intravenous (IV) Iron Drugs Capacity of Key Manufacturers (2015 and 2016)
Table Global Intravenous (IV) Iron Drugs Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Intravenous (IV) Iron Drugs Capacity of Key Manufacturers in 2015
Figure Global Intravenous (IV) Iron Drugs Capacity of Key Manufacturers in 2016
Table Global Intravenous (IV) Iron Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Intravenous (IV) Iron Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Intravenous (IV) Iron Drugs Production Share by Manufacturers
Figure 2016 Intravenous (IV) Iron Drugs Production Share by Manufacturers
Table Global Intravenous (IV) Iron Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Intravenous (IV) Iron Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Intravenous (IV) Iron Drugs Revenue Share by Manufacturers
Table 2016 Global Intravenous (IV) Iron Drugs Revenue Share by Manufacturers
Table Global Market Intravenous (IV) Iron Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Intravenous (IV) Iron Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Intravenous (IV) Iron Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Intravenous (IV) Iron Drugs Product Type
Figure Intravenous (IV) Iron Drugs Market Share of Top 3 Manufacturers
Figure Intravenous (IV) Iron Drugs Market Share of Top 5 Manufacturers
Table Global Intravenous (IV) Iron Drugs Capacity by Regions (2012-2017)
Figure Global Intravenous (IV) Iron Drugs Capacity Market Share by Regions (2012-2017)
Figure Global Intravenous (IV) Iron Drugs Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Intravenous (IV) Iron Drugs Capacity Market Share by Regions
Table Global Intravenous (IV) Iron Drugs Production by Regions (2012-2017)
Figure Global Intravenous (IV) Iron Drugs Production and Market Share by Regions (2012-2017)
Figure Global Intravenous (IV) Iron Drugs Production Market Share by Regions (2012-2017)
Figure 2015 Global Intravenous (IV) Iron Drugs Production Market Share by Regions
Table Global Intravenous (IV) Iron Drugs Revenue by Regions (2012-2017)
Table Global Intravenous (IV) Iron Drugs Revenue Market Share by Regions (2012-2017)
Table 2015 Global Intravenous (IV) Iron Drugs Revenue Market Share by Regions
Table Global Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table China Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table India Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Intravenous (IV) Iron Drugs Consumption Market by Regions (2012-2017)
Table Global Intravenous (IV) Iron Drugs Consumption Market Share by Regions (2012-2017)
Figure Global Intravenous (IV) Iron Drugs Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Intravenous (IV) Iron Drugs Consumption Market Share by Regions
Table North America Intravenous (IV) Iron Drugs Production, Consumption, Import & Export (2012-2017)
Table Europe Intravenous (IV) Iron Drugs Production, Consumption, Import & Export (2012-2017)
Table China Intravenous (IV) Iron Drugs Production, Consumption, Import & Export (2012-2017)
Table Japan Intravenous (IV) Iron Drugs Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Intravenous (IV) Iron Drugs Production, Consumption, Import & Export (2012-2017)
Table India Intravenous (IV) Iron Drugs Production, Consumption, Import & Export (2012-2017)
Table Global Intravenous (IV) Iron Drugs Production by Type (2012-2017)
Table Global Intravenous (IV) Iron Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Intravenous (IV) Iron Drugs by Type (2012-2017)
Figure 2015 Production Market Share of Intravenous (IV) Iron Drugs by Type
Table Global Intravenous (IV) Iron Drugs Revenue by Type (2012-2017)
Table Global Intravenous (IV) Iron Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Intravenous (IV) Iron Drugs by Type (2012-2017)
Figure 2015 Revenue Market Share of Intravenous (IV) Iron Drugs by Type
Table Global Intravenous (IV) Iron Drugs Price by Type (2012-2017)
Figure Global Intravenous (IV) Iron Drugs Production Growth by Type (2012-2017)
Table Global Intravenous (IV) Iron Drugs Consumption by Application (2012-2017)
Table Global Intravenous (IV) Iron Drugs Consumption Market Share by Application (2012-2017)
Figure Global Intravenous (IV) Iron Drugs Consumption Market Share by Application in 2015
Table Global Intravenous (IV) Iron Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Intravenous (IV) Iron Drugs Consumption Growth Rate by Application (2012-2017)
Table AMAG Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table AMAG Pharmaceuticals Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Actavis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Actavis Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Actavis Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Galenica Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Galenica Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Galenica Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Vifor Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Vifor Pharma Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Vifor Pharma Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Luitpold Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Luitpold Pharmaceuticals Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Pharmacosmos A/S Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pharmacosmos A/S Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Pharmacosmos A/S Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table American Regent Basic Information, Manufacturing Base, Production Area and Its Competitors
Table American Regent Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table American Regent Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Fresenius Medical Care AG & Co. KGaA Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Fresenius Medical Care AG & Co. KGaA Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Fresenius Medical Care AG & Co. KGaA Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Anofi US Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Anofi US Intravenous (IV) Iron Drugs Production, Revenue, Price and Gross Margin (2012-2017)
Table Anofi US Intravenous (IV) Iron Drugs Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Intravenous (IV) Iron Drugs
Figure Manufacturing Process Analysis of Intravenous (IV) Iron Drugs
Figure Intravenous (IV) Iron Drugs Industrial Chain Analysis
Table Raw Materials Sources of Intravenous (IV) Iron Drugs Major Manufacturers in 2015
Table Major Buyers of Intravenous (IV) Iron Drugs
Table Distributors/Traders List
Figure Global Intravenous (IV) Iron Drugs Production and Growth Rate Forecast (2017-2021)
Figure Global Intravenous (IV) Iron Drugs Revenue and Growth Rate Forecast (2017-2021)
Table Global Intravenous (IV) Iron Drugs Production Forecast by Regions (2017-2021)
Table Global Intravenous (IV) Iron Drugs Consumption Forecast by Regions (2017-2021)
Table Global Intravenous (IV) Iron Drugs Production Forecast by Type (2017-2021)
Table Global Intravenous (IV) Iron Drugs Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

AMAG Pharmaceuticals, Actavis, Galenica, Vifor Pharma, Luitpold Pharmaceuticals, Pharmacosmos A/S, American Regent, Fresenius Medical Care AG & Co. KGaA, Anofi US, Takeda Pharmaceutical